Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Mar;27(3):454–463.

E-rosette forming cell numbers in the blood of human renal allograft recipients.

G E Kelly, A G Sheil
PMCID: PMC1540922  PMID: 324670

Abstract

The incidence of circulating T lymphocytes (ET-RFC) and a sub-population of T lymphocytes (EE-RFC) were monitored in the blood of seventy-one cadaver renal allograft recipients for the first 2 months after transplantation. In patients with uneventful post-operative courses, the incidence of both ET-RFC and EE-RFC fell promptly upon initiation of immunosuppression returning approximately to pre-operative levels 3-5 weeks after operation; the fall in cell numbers was greatest in those patients receiving adjunct ALG therapy. With the onset of an acute rejection episode, the EE-RFC level rose quickly eventually exceeding the pre-operative level; in 88% (thirty episodes) of cases this rise occurred 1-6 days before clinical diagnosis of rejection and in 12% of cases on the same day as clinical diagnosis. The incidence of ET-RFC rose in conjunction with some cases of acute rejection but remained unchanged in other cases. It is suggested that measurement of the incidence of EE-RFC in blood is valuable in predicting the onset of acute rejection and for the differential diagnosis of acute rejection and ischaemic renal damage.

Full text

PDF
457

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach J. F. Evaluation of T-cells and thymic serum factors in man using the rosette technique. Transplant Rev. 1973;16(0):196–217. doi: 10.1111/j.1600-065x.1973.tb00121.x. [DOI] [PubMed] [Google Scholar]
  2. Bewick M., Ogg C. S., Parsons V., Snowdon S. A., Manuel L. Further assessment of rosette inhibition test in clinical organ transplantation. Br Med J. 1972 Aug 26;3(5825):491–494. doi: 10.1136/bmj.3.5825.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bishop G., Cosimi A. B., Voynow N. K., Whelchel J. D., Wortis H. H. Effect of immunosuppressive therapy for renal allografts on the number of circulating sheep red blood cells rosetting cells. Transplantation. 1975 Aug;20(2):123–129. doi: 10.1097/00007890-197508000-00005. [DOI] [PubMed] [Google Scholar]
  4. Catalona W. J., Potvin C., Chretien P. B. Effect of radiation therapy for urologic cancer on circulating thymus-derived lymphocytes. J Urol. 1974 Aug;112(2):261–267. doi: 10.1016/s0022-5347(17)59703-7. [DOI] [PubMed] [Google Scholar]
  5. Catalona W. J., Potvin C., Chretien P. B. T lymphocytes in bladder and prostatic cancer patients. J Urol. 1974 Sep;112(3):378–382. doi: 10.1016/s0022-5347(17)59735-9. [DOI] [PubMed] [Google Scholar]
  6. Cohnen G., Augener W., Brittinger G., Douglas S. D. Rosette-forming lymphocytes in Hodgkin's disease. N Engl J Med. 1973 Oct 18;289(16):863–863. doi: 10.1056/NEJM197310182891616. [DOI] [PubMed] [Google Scholar]
  7. Cullum P. A., Bewick M., Shilkin K., Tee D. E., Ayliffe P., Hutchison D. C., Laws J. W., Mason S. A., Reid L., Hugh-Jones P. Distinction between infection and rejection in lung transplantation. Br Med J. 1972 Apr 8;2(5805):71–74. doi: 10.1136/bmj.2.5805.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fauci A. S., Dale D. C. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest. 1974 Jan;53(1):240–246. doi: 10.1172/JCI107544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kahan B. D., Mittal K. K., Reisfeld R. A., Terasaki P. I., Bergan J. J. The antigenic stimulus in human transplantation. Surgery. 1973 Jul;74(1):153–162. [PubMed] [Google Scholar]
  11. Kahan B. D., Tom B. H., Mittal K. K., Bergan J. J. Immunodiagnostic test for transplant rejection. Lancet. 1974 Jan 12;1(7846):37–42. doi: 10.1016/s0140-6736(74)93040-2. [DOI] [PubMed] [Google Scholar]
  12. Kaplan M. E., Clark C. An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods. 1974 Jul;5(2):131–135. doi: 10.1016/0022-1759(74)90003-9. [DOI] [PubMed] [Google Scholar]
  13. Richmond D. E., Doak P. B., North J. D. Inhibition of leucocyte migration as an index of rejection in renal transplant recipients. Clin Exp Immunol. 1973 Sep;15(1):17–25. [PMC free article] [PubMed] [Google Scholar]
  14. Sheil A. G., Kelly G. E., Storey B. G., May J., Kalowski S., Mears D., Rogers J. H., Johnson J. R., Charlesworth J., Stewart J. H. Controlled clinical trial of antilymphocyte globulin in patients with renal allografts from cadaver donors. Lancet. 1971 Feb 20;1(7695):359–363. doi: 10.1016/s0140-6736(71)92206-9. [DOI] [PubMed] [Google Scholar]
  15. Smith M. G., Eddleston A. L., Dominguez J. A., Evans D. B., Bewick M., Williams R. Changes in leucocyte migration after renal transplantation. Br Med J. 1969 Nov 1;4(5678):275–278. doi: 10.1136/bmj.4.5678.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stjernswärd J., Jondal M., Vánky F., Wigzell H., Sealy R. Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma. Lancet. 1972 Jun 24;1(7765):1352–1356. doi: 10.1016/s0140-6736(72)91091-4. [DOI] [PubMed] [Google Scholar]
  17. Wood R. F., Gray A. C., Briggs J. D., Bell P. R. The prediction of acute rejection in human renal transplantation using the leucocyte migration test. Transplantation. 1973 Jul;16(1):41–45. doi: 10.1097/00007890-197307000-00008. [DOI] [PubMed] [Google Scholar]
  18. Wybran J., Carr M. C., Fudenberg H. H. Effect of serum on human rosett-forming cells in fetuses and adult blood. Clin Immunol Immunopathol. 1973 Apr;1(3):408–413. doi: 10.1016/0090-1229(73)90057-3. [DOI] [PubMed] [Google Scholar]
  19. Wybran J., Carr M. C., Fudenberg H. H. The human rosette-forming cell as a marker of a population of thymus-derived cells. J Clin Invest. 1972 Oct;51(10):2537–2543. doi: 10.1172/JCI107069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wybran J., Fudenberg H. H. Rosette formation, a test for cellular immunity. Trans Assoc Am Physicians. 1971;84:239–247. [PubMed] [Google Scholar]
  21. Wybran J., Fudenberg H. H. Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest. 1973 May;52(5):1026–1032. doi: 10.1172/JCI107267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wybran J., Levin A. S., Spitler L. E., Fudenberg H. H. Rosette-forming cells, immunologic deficiency diseases and transfer factor. N Engl J Med. 1973 Apr 5;288(14):710–713. doi: 10.1056/NEJM197304052881405. [DOI] [PubMed] [Google Scholar]
  23. Yata J., Tsukimoto I., Arimoto T., Goya N., Tachibana T. Human thymus lymphoid tissue (HTL) antigen, complement receptor and rosette formation with sheep erythrocytes of the lymphocytes from primary immunodeficiency diseases. Clin Exp Immunol. 1973 Jul;14(3):309–317. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES